DM
XLRN
Deerfield Management’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-145,000
| Closed | -$25M | – | 152 |
|
|
2021
Q3 | $25M | Sell |
145,000
-74,500
| -34% | -$12.8M | 0.49% | 57 |
|
|
2021
Q2 | $27.5M | Hold |
219,500
| – | – | 0.49% | 67 |
|
|
2021
Q1 | $29.8M | Sell |
219,500
-202,119
| -48% | -$27.4M | 0.63% | 53 |
|
|
2020
Q4 | $53.9M | Hold |
421,619
| – | – | 1.07% | 26 |
|
|
2020
Q3 | $47.4M | Hold |
421,619
| – | – | 1.16% | 25 |
|
|
2020
Q2 | $40.2M | Buy |
421,619
+78,619
| +23% | +$7.49M | 1.17% | 29 |
|
|
2020
Q1 | $30.8M | Sell |
343,000
-1,026,625
| -75% | -$92.3M | 0.98% | 32 |
|
|
2019
Q4 | $72.6M | Buy |
1,369,625
+64,451
| +5% | +$3.42M | 2.32% | 11 |
|
|
2019
Q3 | $51.6M | Hold |
1,305,174
| – | – | 2.1% | 11 |
|
|
2019
Q2 | $53.6M | Buy |
1,305,174
+50,000
| +4% | +$2.05M | 1.93% | 10 |
|
|
2019
Q1 | $58.5M | Sell |
1,255,174
-131,367
| -9% | -$6.12M | 2.24% | 11 |
|
|
2018
Q4 | $60.4M | Buy |
1,386,541
+268,890
| +24% | +$11.7M | 2.42% | 9 |
|
|
2018
Q3 | $64M | Sell |
1,117,651
-9,149
| -0.8% | -$524K | 2.29% | 11 |
|
|
2018
Q2 | $54.7M | Buy |
1,126,800
+511,800
| +83% | +$24.8M | 1.92% | 12 |
|
|
2018
Q1 | $24M | Hold |
615,000
| – | – | 0.83% | 45 |
|
|
2017
Q4 | $26.1M | Hold |
615,000
| – | – | 1.03% | 37 |
|
|
2017
Q3 | $23M | Buy |
+615,000
| New | +$23M | 1.03% | 33 |
|
|
2016
Q2 | – | Sell |
-353,491
| Closed | -$9.33M | – | 120 |
|
|
2016
Q1 | $9.33M | Buy |
353,491
+140,000
| +66% | +$3.69M | 0.4% | 60 |
|
|
2015
Q4 | $10.4M | Buy |
+213,491
| New | +$10.4M | 0.42% | 61 |
|